tiprankstipranks
Trending News
More News >
Mcpherson'S Limited (AU:MCP)
ASX:MCP
Advertisement

Mcpherson'S Limited (MCP) AI Stock Analysis

Compare
5 Followers

Top Page

AU:MCP

Mcpherson'S Limited

(Sydney:MCP)

Select Model
Select Model
Select Model
Neutral 47 (OpenAI - 4o)
Rating:47Neutral
Price Target:
AU$0.50
▲(92.31% Upside)
Mcpherson's Limited faces significant challenges with profitability and cash flow, which are the most impactful factors on its overall score. Technical indicators show neutral to slightly negative momentum, while valuation metrics highlight concerns with a negative P/E ratio and lack of dividend yield. The absence of earnings call insights and corporate events leaves these areas unaddressed.

Mcpherson'S Limited (MCP) vs. iShares MSCI Australia ETF (EWA)

Mcpherson'S Limited Business Overview & Revenue Model

Company DescriptionMcPherson's Limited provides health, wellness, and beauty products in Australia, New Zealand, Asia, and internationally. It offers beauty care, hair care, skin care, and personal care items, including facial wipes, cotton pads, and foot comfort products; and vitamins and supplements, as well as various kitchen essentials, such as baking papers, cling wraps, and aluminium foils. The company sells its products primarily under the owned brands, including Dr. LeWinn's, A'kin, Manicare, Lady Jayne, Swisspers, Multix, Fusion Health, Oriental Botanicals, Moosehead, and Maseur. The company was founded in 1860 and is based in Kingsgrove, Australia.
How the Company Makes MoneyMcPherson's Limited generates revenue through the sale of its proprietary and agency consumer products across multiple retail channels, including supermarkets, pharmacies, and e-commerce platforms. The company earns income by leveraging its extensive distribution network and established brand portfolio, which includes popular names in the health, wellness, and beauty sectors. In addition, MCP benefits from strategic partnerships and licensing agreements with global brands, enhancing its product offerings and market reach. The company's earnings are influenced by its ability to innovate, maintain strong retailer relationships, and adapt to changing consumer preferences.

Mcpherson'S Limited Financial Statement Overview

Summary
Mcpherson's Limited shows mixed financial health with strong revenue growth but persistent profitability issues. The balance sheet reflects improved leverage but negative returns on equity. Cash flow challenges persist, with declining free cash flow and low cash conversion ratios, indicating potential liquidity concerns.
Income Statement
45
Neutral
Mcpherson's Limited has experienced fluctuating revenue growth, with a notable 24.14% increase in the latest period, but has consistently faced negative net profit margins, indicating ongoing profitability challenges. The gross profit margin improved significantly to 57.88%, but negative EBIT and EBITDA margins highlight operational inefficiencies.
Balance Sheet
55
Neutral
The company's debt-to-equity ratio has improved to 0.10, reflecting better leverage management. However, the return on equity remains negative, indicating challenges in generating returns for shareholders. The equity ratio is stable, suggesting a balanced asset structure.
Cash Flow
40
Negative
Free cash flow has declined significantly by 68.55%, raising concerns about cash generation. The operating cash flow to net income ratio is low, indicating potential issues in converting income into cash. However, the free cash flow to net income ratio is relatively strong, suggesting some efficiency in cash utilization.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue138.99M138.99M144.63M155.23M214.00M200.50M
Gross Profit80.45M80.45M35.09M47.77M90.80M87.48M
EBITDA-6.99M-6.99M-4.92M3.10M7.44M5.98M
Net Income-15.04M-15.04M-15.99M-5.06M333.00K-5.37M
Balance Sheet
Total Assets117.21M117.21M146.90M190.06M215.76M199.59M
Cash, Cash Equivalents and Short-Term Investments9.48M9.48M24.77M7.03M13.14M7.35M
Total Debt7.30M7.30M19.85M25.45M29.38M20.93M
Total Liabilities44.23M44.23M57.26M80.61M94.95M84.96M
Stockholders Equity72.98M72.98M89.64M109.45M120.81M114.62M
Cash Flow
Free Cash Flow1.57M1.57M9.64M4.70M16.32M168.00K
Operating Cash Flow2.21M2.21M12.34M6.55M18.57M2.69M
Investing Cash Flow-3.62M-3.62M16.29M-1.85M-2.25M-31.80M
Financing Cash Flow-13.91M-13.91M-10.90M-10.91M-10.59M29.42M

Mcpherson'S Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.26
Price Trends
50DMA
0.28
Negative
100DMA
0.27
Negative
200DMA
0.28
Negative
Market Momentum
MACD
>-0.01
Negative
RSI
42.90
Neutral
STOCH
60.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:MCP, the sentiment is Negative. The current price of 0.26 is below the 20-day moving average (MA) of 0.26, below the 50-day MA of 0.28, and below the 200-day MA of 0.28, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 42.90 is Neutral, neither overbought nor oversold. The STOCH value of 60.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:MCP.

Mcpherson'S Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
AU$31.73M6.0414.70%1.61%6.89%607.27%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
58
Neutral
AU$102.65M129.631.90%1.58%-65.09%
47
Neutral
€38.87M-20.06%8.87%-3.91%5.94%
47
Neutral
AU$35.49M-24.80%2.35%95.03%
46
Neutral
€8.86M-22.96%109.38%-25.16%77.62%
30
Underperform
$3.15M12.92%34.21%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:MCP
Mcpherson'S Limited
0.26
-0.16
-38.55%
AU:PTL
Pental Ltd.
0.05
-0.03
-40.23%
AU:ABY
Adore Beauty Group Ltd.
1.05
0.01
0.96%
AU:SKN
Skin Elements Limited
AU:CCX
City Chic Collective Limited
0.09
-0.03
-25.00%
AU:S66
Star Combo Pharma Ltd.
0.24
0.10
71.43%

Mcpherson'S Limited Corporate Events

McPherson’s Limited Reports FY25 Revenue and Transformation Progress
Jul 17, 2025

McPherson’s Limited has reported expected revenue of $139 million for FY25, with four out of five core brands achieving revenue growth despite challenging conditions. The company has transitioned to a new operating model involving third-party warehousing and pharmacy wholesaler partnerships, which is expected to unlock EBIT benefits of $4 to $5 million annually. This strategic shift is aimed at supporting future growth and enhancing brand investment, positioning McPherson’s for improved operational performance in FY26.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 08, 2025